Publisher Correction: Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.
Dong B, Xu JY, Huang Y, Guo J, Dong Q, Wang Y, Li N, Liu Q, Zhang M, Pan Q, Wang H, Jiang J, Chen B, Shen D, Ma Y, Zhai L, Zhang J, Li J, Xue W, Tan M, Qin J.
Dong B, et al. Among authors: jiang j.
Nat Cancer. 2024 Nov;5(11):1754. doi: 10.1038/s43018-024-00845-7.
Nat Cancer. 2024.
PMID: 39354226
No abstract available.